# Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy

> **NCT03612973** · NA · COMPLETED · sponsor: **Assiut University** · enrollment: 80 (actual)

## Conditions studied

- Chronic Hepatitis c

## Interventions

- **DIAGNOSTIC_TEST:** lipid profile
- **DIAGNOSTIC_TEST:** fasting insulin
- **DIAGNOSTIC_TEST:** fibro scan

## Key facts

- **NCT ID:** NCT03612973
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03612973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03612973, "Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT03612973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*